Low brain serotonin transporter binding in major depressive disorder

Psychiatry Research - Neuroimaging

Volumn 202, Issue 2, 2012, Pages 161-167

  Newberg, Andrew B ^a,b   Amsterdam, Jay D ^c   Wintering, Nancy ^a   Shults, Justine ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Basal ganglia; Biomarker; Major depression; Medial temporal lobe; Midbrain; Serotonin transporter; Single photon emission computed tomography (SPECT)

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MESENCEPHALON; PRIORITY JOURNAL; PROTEIN BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

ADULT; BRAIN; BRAIN MAPPING; CINANSERIN; DEPRESSIVE DISORDER, MAJOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; ROC CURVE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84863882525     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.12.015     Document Type: Article

References (53)

1. 123)I]ADAM and SPECT. Journal of Nuclear Medicine 2001, 42:1556-1562.
2. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Research 1995, 688:121-133.
3. Bennett M.R., Hacker P.M. Emotion and cortical-subcortical function, conceptual developments. Progress in Neurobiology 2005, 75:29-52.
4. Biver F., Wikler D., Lotstra F., Damhaut P., Goldman S., Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression, focal changes in orbito-insular cortex. The British Journal of Psychiatry 1997, 171:444-448.
5. 123)I-ADAM SPECT study. Psychopharmacology (Berlin) 2006, 189:145-153.
6. Chou Y.H., Wang S.J., Lin C.L., Mao W.C., Lee S.M., Liao M.H. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disorders 2010, 12:312-318.
7. Conway P.G., Brunswick D.J. High- and low-affinity binding components for [3H]imipramine in rat cerebral cortex. Journal of Neurochemistry 1985, 45:206-209.
8. 11C]citalopram. International Journal of Radiation Applications and Instrumentation 1990, 41:541-543.
9. Das M.K., Mukherjee J. Radiosynthesis of [F-18]fluoxetine as a potential radiotracer for serotonin reuptake sites. Applied Radiation and Isotopes 1993, 44:835-842.
10. D'haenen H., Bossuyt A., Mertens J., Bossuyt-Piron C., Gijsemans M., Kaufman L. SPECT imaging of serotonin2 receptors in depression. Psychiatry Research: Neuroimaging 1992, 45:227-237.
11. Eggers B., Hermann W., Barthel H., Sabri O., Wagner A., Hesse S. The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease. Journal of Neurology 2003, 250:576-580.
12. 123I]ADAM, a SPECT validation study. European Journal of Nuclear Medicine and Molecular Imaging 2005, 32:1329-1336.
13. Erritzoe D., Frokjaer V.G., Haahr M.T., Kalbitzer J., Svarer C., Holst K.K., Hansen D.L., Jernigan T.L., Lehel S., Knudsen G.M. Cerebral serotonin transporter binding is inversely related to body mass index. NeuroImage 2010, 52:284-289.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition with Psychotic Screen (SCID-I/PW/PSY SCREEN) 2001, Biometrics Research, New York State Psychiatric Institute, New York.
15. 3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain. Neuropsychopharmacology 1996, 14:309-323.
16. 11C]DASB-PET in depressed and non-depressed patients infected with HIV. NeuroImage 2010, 49:2588-2595.
17. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., Knable M.B., Gorey J.G., Doty L., Geyer C., Lee K.S., Coppola R., Weinberger D.R., Linnoila M. Reduced central serotonin transporters in alcoholism. The American Journal of Psychiatry 1998, 155(11):1544-1549.
18. Heinz A., Jones D.W., Gorey J.G., Bennet A., Suomi S.J., Weinberger D.R., Higley J.D. Serotonin transporter availability correlates with alcohol intake in non-human primates. Molecular Psychiatry 2003, 8(2):231-234.
19. 123I]ADAM. Journal of Neural Transmission 2006, 113(5):659-6670.
20. Hsieh P.C., Lee I.H., Yeh T.L., Chen K.C., Huang H.C., Chen P.S., Yang Y.K., Yao W.J., Lu R.B., Chiu N.T. Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study. Psychiatry Research: Neuroimaging 2010, 184:157-161.
21. 11C](+)McN5652. Biological Psychiatry 2002, 51:715-722.
22. Ito H., Kawashima R., Awata S., Ono S., Sato K., Goto R., Koyama M., Sato M., Fukuda H. Hypoperfusion in the limbic system and prefrontal cortex in depression, SPECT with anatomic standardization technique. Journal of Nuclear Medicine 1996, 37:410-414.
23. 123)I] nor-beta-CIT SPECT imaging. Psychiatry Research: Neuroimaging 2007, 154:125-131.
24. Joensuu M., Lehto S.M., Tolmunen T., Saarinen P.I., Valkonen-Korhonen M., Vanninen R., Ahola P., Tiihonen J., Kuikka J., Pesonen U., Lehtonen J. Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression. Psychiatry and Clinical Neuroscience 2010, 64:387-393.
25. Kalbitzer J., Erritzoe D., Holst K.K., Nielsen F.A., Marner L., Lehel S., Arentzen T., Jernigan T.L., Knudsen G.M. Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes. Biological Psychiatry 2010, 67:1033-1039.
26. Kovachich G.B., Aronson C.E., Brunswick D.J. Effect of repeated administration of antidepressants on serotonin uptake sites in limbic and neocortical structures of rat brain determined by quantitative autoradiography. Neuropsychopharmacology 1992, 7:317-324.
27. Kugaya A., Seneca N.M., Snyder P.J., Williams S.A., Malison R.T., Baldwin R.M., Seibyl J.P., Innis R.B. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 2003, 28:413-420.
28. 3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls. Journal of Psychiatry & Neuroscience 1997, 22:185-191.
29. Leake A., Fairbairn A.F., McKeith I.G., Ferrier I.N. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain, neurochemical and clinical correlates. Psychiatry Research 1991, 39:155-165.
30. 123I]nor-beta-CIT in atypical depression. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30:1251-1255.
31. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biological Psychiatry 1998, 44:1090-1098.
32. Massou J.M., Trichard C., Attar-Levy D., Feline A., Corruble E., Beaufils B., Martinot J.L. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berlin) 1997, 133:99-101.
33. Meyer J.H., Kapur S., Houle S., DaSilva J., Owczarek B., Brown G.M., Wilson A.A., Kennedy S.H. Prefrontal cortex 5-HT2 receptors in depression, an [18F]setoperone PET imaging study. The American Journal of Psychiatry 1999, 56:1029-1034.
34. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., Goulding V., Kennedy J., Wilson A.A. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry 2004, 61:1271-1279.
35. 123)I-ADAM: a serotonin transporter imaging agent. Journal of Nuclear Medicine 2004, 45:834-841.
36. 123I ADAM binding to serotonin transporters in patients with major depression and healthy controls, a preliminary study. Journal of Nuclear Medicine 2005, 46:993-997.
37. Oda K., Okubo Y., Ishida R., Murata Y., Ohta K., Matsuda T., Matsushima E., Ichimiya T., Suhara T., Shibuya H., Nishikawa T. Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity. Biological Psychiatry 2003, 53:150-156.
38. Oya S., Choi S.R., Hou C., Mu M., Kung M.P., Acton P.D., Siciliano M., Kung H.F. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM), an improved serotonin transporter ligand. Nuclear Medicine and Biology 2000, 27:249-254.
39. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., Mann J.J. Lower serotonin transporter binding potential in the human brain during major depressive episodes. The American Journal of Psychiatry 2006, 163:52-58.
40. 11C]DASB PET study. Molecular Psychiatry 2008, 13:606-613.
41. 11)C](+)McN5652 shows increased serotonin transporter availability in major depression. Journal of Affective Disorders 2004, 82:321-327.
42. Resnick S.M., Karp J.S., Tretsky B.I., Gur R.E. Comparison of anatomically defined versus physiologically based regional localization: Effects on PET-FDG quantitation. Journal of Nuclear Medicine 1993, 34:201-208.
43. 123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. European Journal of Nuclear Medicine and Molecular Imaging 2009, 36:841-849.
44. Scheffel U., Dannals R.F., Suehiro M., Ricaurte G.A., Carroll F.I., Kuhar M.J., Wagner H.N. Development of PET/SPECT ligands for the serotonin transporter. NIDA Research Monograph 1994, 138:111-130.
45. Staley J.K., Sanacora G., Tamagnan G. Sex differences in diencephalons serotonin transporter availability in major depression. Biological Psychiatry 2005, 59:40-47.
46. Suehiro M., Wilson A.A., Scheffel U., Dannals R.F., Ravert H.T., Wagner H.N. Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)-paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET. Nuclear Medicine and Biology 1991, 18:791-796.
47. Suehiro M., Scheffel U., Dannals R.F., Ravert H.T., Ricaurte G.A., Wagner H.N. A PET radiotracer for studying serotonin uptake sites, carbon-11-McN-5652Z. Journal of Nuclear Medicine 1993, 34:120-127.
48. 11C]McN5652 extraction of characteristic images by artificial neural-network analysis. Behavioral Brain Research 1995, 73:221-224.
49. Tsai H.C., Yeh T.L., Hsieh M.H., Lee I.H., Chen K.C., Chen P.S., Yang Y.K., Yao W.J. Association between serotonin transporter availability and overall rating scores of quality of life in healthy volunteers. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:711-714.
50. Uusitalo A.L., Valkonen-Korhonen M., Helenius P., Vanninen E., Bergström K.A., Kuikka J.T. Abnormal serotonin reuptake in an overtrained, insomnic and depressed team athlete. International Journal of Sports Medicine 2004, 25:150-153.
51. 123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biological Psychiatry 2000, 47:482-489.
52. Williams J.B.W. A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry 1988, 45:742-747.
53. Yatham L.N., Liddle P.F., Dennie J., Shiah I.S., Adam M.J., Lane C.J., Lam R.W., Ruth T.J. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment, a positron emission tomography study with fluorine-18-labeled setoperone. Archives of General Psychiatry 1999, 56:705-711.